Is Genpact (G) Quietly Recasting Its Moat Around Agentic AI And Partner-Led Growth?
Genpact Limited G | 37.74 | +1.37% |
- In late February 2026, Genpact was highlighted by Zacks Investment Research for its higher-than-industry expected EPS and sales growth, efficient asset utilization, and upward earnings estimate revisions, underscoring improving growth metrics versus professional services peers.
- Genpact’s recent quarter also underscored its push into higher-margin, AI-driven “agentic operations,” with around 330 GenAI solutions deployed and partner-related revenue rising sharply through collaborations with AWS, Google Cloud, and Databricks.
- Against this backdrop, we’ll explore how Genpact’s sharpened focus on agentic, AI-powered operations influences its existing investment narrative and growth assumptions.
Uncover the next big thing with 30 elite penny stocks that balance risk and reward.
Genpact Investment Narrative Recap
To own Genpact, you need to believe its shift from legacy BPO to higher-margin, AI-powered “agentic operations” can offset softer core services and support earnings growth. The Zacks recognition around higher expected EPS and sales growth reinforces that this transition is gaining traction, but it does not remove the key near term risk that weaker demand or delayed large deals could still weigh on revenue momentum and margins.
Among recent announcements, the full year 2025 results and 2026 outlook stand out in this context, as they frame how Genpact’s AI and cloud partnerships might translate into at least 7% net revenue growth and US$3.48 in expected diluted EPS for 2026. Taken together with roughly 330 GenAI solutions already in production and rising partner-related revenue from AWS, Google Cloud, and Databricks, these numbers provide a clearer yardstick to watch whether agentic operations can meaningfully offset any deceleration in the legacy business.
However, even as AI rich offerings scale, investors should be aware that...
Genpact's narrative projects $5.9 billion revenue and $669.6 million earnings by 2028.
Uncover how Genpact's forecasts yield a $48.64 fair value, a 19% upside to its current price.
Exploring Other Perspectives
Four fair value estimates from the Simply Wall St Community span roughly US$35 to nearly US$113 per share, showing how far apart individual views can be. Against that backdrop, Genpact’s reliance on clients adopting higher value, AI enabled, multi year solutions highlights why you may want to compare several perspectives before deciding how its growth ambitions could play out.
Explore 4 other fair value estimates on Genpact - why the stock might be worth over 2x more than the current price!
Form Your Own Verdict
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your Genpact research is our analysis highlighting 4 key rewards that could impact your investment decision.
- Our free Genpact research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Genpact's overall financial health at a glance.
Searching For A Fresh Perspective?
Every day counts. These free picks are already gaining attention. See them before the crowd does:
- The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 21 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
- The future of work is here. Discover the 31 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
- Capitalize on the AI infrastructure supercycle with our selection of the 35 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
